ProtEAMPs · Protease activated encrypted antimicrobial peptides
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-08-01 → 2028-07-31
- Финансиране от ЕС
- 296 144 €
- Участници
- 2
- Схема
- HORIZON-TMA-MSCA-PF-GF
Линиите свързват координатора с партньорите.
Накратко на български
Скрити антимикробни пептиди, които се активират чрез специфични ензими (протеази), се изучават за създаване на нови лекарства. Това е важно, защото бактериите стават устойчиви на обикновените антибиотици, което застрашава здравето на хората в световен мащаб.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
Antimicrobial resistance (AMR) is a global concern, with reduction a priority for bodies such as the UN, EU, and WHO. By 2050, AMR-related deaths may rival those caused by cancer. Antimicrobial peptides (AMPs) offer a promising alternative, being less prone to resistance than conventional antibiotics. Recently, encrypted AMPs (EAMPs), sequences hidden within larger proteins, have been discovered across humans and other organisms. Understanding how these EAMPs are revealed offers insight into immunogenicity and inspires next-generation therapeutics, particularly protease-activated encrypted AMPs (ProtEAMPs). This fellowship will be hosted by the de la Fuente lab (Penn) and the Hartrampf lab (UZH), providing access to unique technologies: high-performance computational models for AMP design (Penn) and automated flow peptide synthesis (AFPS), currently only available at UZH in Europe. Historically, AMP design has focused on shortening sequences to reduce cost. This project takes a novel approach by designing longer EAMP prodrug derivatives (>50 amino acids), aiming to enhance potency and specificity. Computational tools will be used to study AMP unveiling pathways, protease co-evolution, and design of next-gen AMP proteins. Regular subgroup and group meetings, targetted mentoring, and institutional training at both universities will support development in leadership, teaching, and public engagement. Outreach activities will communicate the potential of computational modelling and peptide synthesis to wider audiences. EAMPs remain poorly understood. Exploring their presence in non-immunogenic proteins could unlock new insights into the human proteome and its evolution. Validating next-gen AMP proteins could revolutionize treatment for multidrug-resistant infections, cutting costs, reducing treatment time, and saving lives. This project supports EU Horizon objectives as well as UN strategic goals and will help redefine how we understand and harness our own biology.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITAT ZURICH · ZurichКоординаторШвейцария
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP · PhiladelphiaСъединени щати
Връзки
Данни: CORDIS, © Европейски съюз
